Hong-Wei Sun
About
In The Last Decade
Hong-Wei Sun
18 papers receiving 552 citations
Peers
Comparison fields: 5 of 74
- Immunology 331
- Oncology 207
- Molecular Biology 179
- Cancer Research 132
- Pulmonary and Respiratory Medicine 43
Countries citing papers authored by Hong-Wei Sun
This map shows the geographic impact of Hong-Wei Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hong-Wei Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hong-Wei Sun more than expected).
Fields of papers citing papers by Hong-Wei Sun
This network shows the impact of papers produced by Hong-Wei Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hong-Wei Sun. The network helps show where Hong-Wei Sun may publish in the future.
Co-authorship network of co-authors of Hong-Wei Sun
This figure shows the co-authorship network connecting the top 25 collaborators of Hong-Wei Sun. A scholar is included among the top collaborators of Hong-Wei Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hong-Wei Sun. Hong-Wei Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 3 | |
| 4 | 7 | |
| 5 | 8 | |
| 6 | 10 | |
| 7 | 9 | |
| 8 | 2 | |
| 9 | 2 | |
| 10 | 82 | |
| 11 | 33 | |
| 12 | 20 | |
| 13 | 6 | |
| 14 | 49 | |
| 15 | 0 | |
| 16 | 91 | |
| 17 | 160 | |
| 18 | [Relationship between the efficacy of gemcitabine/cisplatin adjuvant chemotherapy and RRM1 protein expression in postoperative NSCLC patients]. | 1 |
| 19 | 3 | |
| 20 | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.